El-Kady Asmaa M, Abdel-Rahman Iman A M, Fouad Samer S, Allemailem Khaled S, Istivan Taghrid, Ahmed Sheren F M, Hasan Al Shaimaa, Osman Heba A, Elshabrawy Hatem A
Department of Medical Parasitology, Faculty of Medicine, South Valley University, Qena 83523, Egypt.
Department of Pharmacognosy, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt.
Antibiotics (Basel). 2021 Jun 11;10(6):705. doi: 10.3390/antibiotics10060705.
Giardiasis is a major diarrheal disease affecting approximately 2.5 million children annually in developing countries. Several studies have reported the resistance of () to multiple drugs. Therefore, identifying an effective drug for giardiasis is a necessity. This study examined the antiparasitic effect of (pomegranate) and evaluated its therapeutic efficacy in rats infected with . In vitro study showed high efficacy of pomegranate peel ethanolic extract in killing cysts as demonstrated by eosin vital staining. We showed that treating infected rats with pomegranate extract resulted in a marked reduction in the mean number of cysts and trophozoites in feces and intestine respectively. Interestingly, the number of trophozoites and cysts were significantly lower in the pomegranate extract-treated group compared to the metronidazole-positive control group. Moreover, pomegranate extract treatment significantly induced nitric oxide (NO) and reduced serum IL-6 and TNF-α, compared to infected untreated rats. Histological and scanning electron microscopy (SEM) examination of the jejunum and duodenum of pomegranate extract-treated animals confirmed the antiparasitic effect of the extract, and demonstrated the restoration of villi structure with reduction of villi atrophy, decreased infiltration of lymphocytes, and protection of intestinal cells from apoptotic cell death. In conclusion, our data show that the pomegranate peel extract is effective in controlling infections, which suggests that it could be a viable treatment option for giardiasis.
贾第虫病是一种主要的腹泻疾病,在发展中国家每年影响约250万儿童。多项研究报告了(贾第虫)对多种药物的耐药性。因此,确定一种治疗贾第虫病的有效药物很有必要。本研究检测了(石榴)的抗寄生虫作用,并评估了其对感染贾第虫的大鼠的治疗效果。体外研究表明,通过伊红活细胞染色证明,石榴皮乙醇提取物在杀死贾第虫囊肿方面具有高效性。我们发现,用石榴提取物治疗感染的大鼠会导致粪便和肠道中贾第虫囊肿和滋养体的平均数量显著减少。有趣的是,与甲硝唑阳性对照组相比,石榴提取物治疗组中的贾第虫滋养体和囊肿数量显著更低。此外,与未治疗的感染大鼠相比,石榴提取物治疗显著诱导了一氧化氮(NO)的产生,并降低了血清白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)。对石榴提取物治疗的动物空肠和十二指肠进行组织学和扫描电子显微镜(SEM)检查,证实了该提取物的抗寄生虫作用,并显示绒毛结构得以恢复,绒毛萎缩减少,淋巴细胞浸润减少,肠道细胞免受凋亡性细胞死亡的影响。总之,我们的数据表明石榴皮提取物在控制贾第虫感染方面有效,这表明它可能是治疗贾第虫病的一个可行选择。